67 related articles for article (PubMed ID: 11527011)
1. Menjugate (Chiron).
Jones DH
Curr Opin Investig Drugs; 2001 Jan; 2(1):47-9. PubMed ID: 11527011
[TBL] [Abstract][Full Text] [Related]
2. Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months.
Prescrire Int; 2003 Apr; 12(64):43-6. PubMed ID: 12675020
[TBL] [Abstract][Full Text] [Related]
3. Meningitis C vaccine (North American vaccine).
Lattanzi M; Del Giudice G
Curr Opin Investig Drugs; 2002 Jan; 3(1):51-3. PubMed ID: 12054072
[TBL] [Abstract][Full Text] [Related]
4. Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine.
Mehlhorn AJ; Balcer HE; Sucher BJ
Ann Pharmacother; 2006 Apr; 40(4):666-73. PubMed ID: 16595570
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
7. Varivax (Merck & Co).
Jones T
Curr Opin Investig Drugs; 2002 Jan; 3(1):54-7. PubMed ID: 12054073
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
Trotter CL; Ramsay ME
FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
[TBL] [Abstract][Full Text] [Related]
10. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
12. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal C vaccines: the Canadian experience.
De Wals P
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
[TBL] [Abstract][Full Text] [Related]
14. Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
Campbell JD; Edelman R; King JC; Papa T; Ryall R; Rennels MB
J Infect Dis; 2002 Dec; 186(12):1848-51. PubMed ID: 12447774
[TBL] [Abstract][Full Text] [Related]
15. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.
Borrow R; Miller E
Expert Rev Vaccines; 2006 Dec; 5(6):851-7. PubMed ID: 17184222
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
[TBL] [Abstract][Full Text] [Related]
17. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
[TBL] [Abstract][Full Text] [Related]
18. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
[TBL] [Abstract][Full Text] [Related]
19. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
Magdzik W
Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
[TBL] [Abstract][Full Text] [Related]
20. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]